NO942228L - Ipsapiron-legemiddeltilberedning - Google Patents
Ipsapiron-legemiddeltilberedningInfo
- Publication number
- NO942228L NO942228L NO942228A NO942228A NO942228L NO 942228 L NO942228 L NO 942228L NO 942228 A NO942228 A NO 942228A NO 942228 A NO942228 A NO 942228A NO 942228 L NO942228 L NO 942228L
- Authority
- NO
- Norway
- Prior art keywords
- hours
- release
- ipsapirone
- drug preparation
- ipsaplron
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4319760A DE4319760A1 (de) | 1993-06-15 | 1993-06-15 | Ipsapiron Arzneimittelzubereitung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942228D0 NO942228D0 (no) | 1994-06-14 |
| NO942228L true NO942228L (no) | 1994-12-16 |
Family
ID=6490360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942228A NO942228L (no) | 1993-06-15 | 1994-06-14 | Ipsapiron-legemiddeltilberedning |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0629402A1 (sv) |
| JP (1) | JPH06345649A (sv) |
| KR (1) | KR950000150A (sv) |
| CN (1) | CN1099263A (sv) |
| AU (1) | AU6345794A (sv) |
| CA (1) | CA2125620A1 (sv) |
| CZ (1) | CZ146494A3 (sv) |
| DE (1) | DE4319760A1 (sv) |
| FI (1) | FI942803A7 (sv) |
| HU (1) | HUT70759A (sv) |
| IL (1) | IL109993A0 (sv) |
| NO (1) | NO942228L (sv) |
| NZ (1) | NZ260732A (sv) |
| PL (1) | PL303822A1 (sv) |
| SK (1) | SK72494A3 (sv) |
| ZA (1) | ZA944187B (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706089D0 (en) * | 1997-03-24 | 1997-05-14 | Scherer Ltd R P | Pharmaceutical composition |
| EP1140105B1 (en) * | 1998-12-24 | 2003-10-22 | Janssen Pharmaceutica N.V. | Controlled release galantamine composition |
| WO2004103338A1 (en) * | 2003-05-19 | 2004-12-02 | Bioprogress Plc | Adhesives and film modifying compositions |
| EP4062913B1 (en) * | 2020-09-02 | 2024-05-08 | Beijing Biostar Pharmaceuticals Co., Ltd. | Solid oral formulation of utidelone |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0386440T3 (da) * | 1989-02-11 | 1992-09-14 | Bayer Ag | Lægemidler med kontrolleret afgivelse af virksomt stof |
| DD297767A5 (de) * | 1990-03-06 | 1992-01-23 | Bayer Aktiengesellschaft,De | Arzneimittel mit kontrollierter wirkstoffabgabe |
| JPH04360826A (ja) * | 1991-06-07 | 1992-12-14 | Bayer Yakuhin Kk | 放出制御製剤 |
-
1993
- 1993-06-15 DE DE4319760A patent/DE4319760A1/de not_active Withdrawn
-
1994
- 1994-05-31 AU AU63457/94A patent/AU6345794A/en not_active Abandoned
- 1994-06-03 EP EP94108571A patent/EP0629402A1/de not_active Withdrawn
- 1994-06-09 JP JP6150640A patent/JPH06345649A/ja active Pending
- 1994-06-10 CA CA002125620A patent/CA2125620A1/en not_active Abandoned
- 1994-06-13 NZ NZ260732A patent/NZ260732A/en unknown
- 1994-06-13 PL PL94303822A patent/PL303822A1/xx unknown
- 1994-06-13 FI FI942803A patent/FI942803A7/sv unknown
- 1994-06-13 IL IL10999394A patent/IL109993A0/xx unknown
- 1994-06-14 SK SK724-94A patent/SK72494A3/sk unknown
- 1994-06-14 HU HU9401771A patent/HUT70759A/hu unknown
- 1994-06-14 CZ CZ941464A patent/CZ146494A3/cs unknown
- 1994-06-14 ZA ZA944187A patent/ZA944187B/xx unknown
- 1994-06-14 KR KR1019940013308A patent/KR950000150A/ko not_active Withdrawn
- 1994-06-14 NO NO942228A patent/NO942228L/no unknown
- 1994-06-15 CN CN94106657A patent/CN1099263A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1099263A (zh) | 1995-03-01 |
| NZ260732A (en) | 1996-02-27 |
| KR950000150A (ko) | 1995-01-03 |
| IL109993A0 (en) | 1994-10-07 |
| FI942803L (sv) | 1994-12-16 |
| DE4319760A1 (de) | 1994-12-22 |
| ZA944187B (en) | 1995-02-08 |
| NO942228D0 (no) | 1994-06-14 |
| JPH06345649A (ja) | 1994-12-20 |
| FI942803A0 (sv) | 1994-06-13 |
| CZ146494A3 (en) | 1995-01-18 |
| EP0629402A1 (de) | 1994-12-21 |
| FI942803A7 (sv) | 1994-12-16 |
| SK72494A3 (en) | 1995-04-12 |
| PL303822A1 (en) | 1995-01-09 |
| HU9401771D0 (en) | 1994-09-28 |
| CA2125620A1 (en) | 1994-12-16 |
| HUT70759A (en) | 1995-10-30 |
| AU6345794A (en) | 1994-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2180816A1 (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
| CA2193337A1 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
| CA2327973A1 (en) | Storage system for powdered pharmaceuticals, and inhaler equipped with this system | |
| AU6995794A (en) | Aspb28 insulin crystals | |
| TR199802034T2 (xx) | �apraz ba�lant�l� amylose ve hydroxypropylmethylcellulose baz�nda bir ta��y�c� i�eren kontroll� ��z�l�ml� farmas�tik tablet. | |
| GEP20012442B (en) | Irreversible Inhibitors of Tyrosine Kinases | |
| IT8719064A0 (it) | Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive. | |
| DK1171573T3 (da) | ARPE-19, som en platform-cellelinie for indkapslet cellebaseret indgivelse | |
| NO953278D0 (no) | Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette | |
| AU692430C (en) | Aqueous pharmaceutical preparations of G-CSF with a long shelf life | |
| WO1994012165A3 (en) | Enzyme inhibitors | |
| UA66417C2 (en) | Recombinant adenovirus affecting canines, pharmaceutical composition | |
| EP1452172A3 (en) | Multiple unit pharmaceutical preparation | |
| CA2264901A1 (fr) | Association inhibiteurs de no synthase et piegeurs des formes reactives de l'oxygene | |
| CA2030838A1 (en) | Preparations containing l-carnitine | |
| ATE397665T1 (de) | Lymphotoxin-beta, lymphotoxin-beta komplexe, pharmazeutische zubereitungen und therapeutische verwendungen davon | |
| EP0147146A3 (en) | Enhancement of transdermal drug delivery | |
| IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
| CO5011082A1 (es) | Formulacion medicamentosa con liberacion controlada de sus- tancia activa | |
| TW327602B (en) | A pharmaceutical composition of an ophthalmic suspension containing difluprednate | |
| EP0514464A4 (en) | Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell | |
| NO942228L (no) | Ipsapiron-legemiddeltilberedning | |
| AU687623B2 (en) | Cell Adhesion peptides for use in modifying mutual adhesion among eukaryotic cells | |
| NO994898D0 (no) | Cytomodulering av lipofile peptider for aa modulere immunsystemaktivitet og inhibere inflammasjon | |
| CA2185883A1 (en) | The use of dimeticone as a transport and carrier system and/or drug delivery system |